Comparing biomarkers as trial level general surrogates 0 个回复 - 893 次查看
An intermediate response measure that accurately predicts efficacy in a new setting can reduce trial cost and time to product licensure. In this article, we define a trial level general surrogate, whi ...2016-4-4 14:51 - oliyiyi - LATEX论坛